Rankings
▼
Calendar
AKBA Q3 2016 Earnings — Akebia Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
AKBA
Akebia Therapeutics, Inc.
$375M
Q3 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$31M
Operating Income
-$36M
Net Income
-$36M
EPS (Diluted)
$-0.96
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$28M
Free Cash Flow
-$29M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$169M
Total Liabilities
$68M
Stockholders' Equity
$101M
Cash & Equivalents
$66M
← FY 2016
All Quarters
Q4 2016 →